Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.

Gaines AR, Lee-Stroka H, Byrne K, Scott DE, Uhl L, Lazarus E, Stroncek DF.

Transfusion. 2009 Jun;49(6):1050-8. doi: 10.1111/j.1537-2995.2008.02083.x. Epub 2009 Feb 9.

2.

Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia.

Levendoglu-Tugal O, Jayabose S.

J Pediatr Hematol Oncol. 2001 Oct;23(7):460-3.

PMID:
11878583
3.

What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?

Garratty G.

Transfusion. 2009 Jun;49(6):1026-31. doi: 10.1111/j.1537-2995.2009.02216.x. No abstract available. Erratum in: Transfusion. 2009 Aug;49(8):1774.

PMID:
19638151
4.
7.

Intravenous Rh immune globulin for treating immune thrombocytopenic purpura.

Sandler SG.

Curr Opin Hematol. 2001 Nov;8(6):417-20. Review. Erratum in: Curr Opin Hematol 2002 Mar;9(2):179.

PMID:
11604585
8.

Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.

Rushin J, Rumsey DH, Ewing CA, Sandler SG.

Transfusion. 2000 May;40(5):551-4.

PMID:
10827257
9.

Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.

Alioglu B, Avci Z, Ozyurek E, Ozbek N.

J Pediatr Hematol Oncol. 2007 Sep;29(9):636-9.

PMID:
17805040
10.

A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP).

Tarantino MD, Bussel JB, Cines DB, McCrae KR, Gernsheimer T, Liebman HA, Wong WY, Kulkarni R, Grabowski E, McMillan R.

Blood. 2007 Jun 15;109(12):5527; author reply 5528. No abstract available.

11.

Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin.

Winiecki S, Baer B, Chege W, Jankosky C, Mintz P, Baker M, Woodworth T, Nguyen M.

Transfusion. 2015 Jul;55 Suppl 2:S28-35. doi: 10.1111/trf.13116.

PMID:
26174895
12.

Severe hemolysis following administration of Rh(o)(D) immune globulin in an ITP patient associated with anti-C.

Schwartz J, Spitalnik S, Grima KM.

Blood. 2006 Mar 15;107(6):2585. No abstract available.

13.

Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura.

Kees-Folts D, Abt AB, Domen RE, Freiberg AS.

Pediatr Nephrol. 2002 Feb;17(2):91-6. Review.

PMID:
11875670
14.

Acute hemolysis of transfused A2 red cells by an auto-HI antibody.

Darabi K, Makar RS.

Transfusion. 2008 May;48(5):964-8. doi: 10.1111/j.1537-2995.2008.01661.x.

PMID:
18454737
15.
17.

Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.

Rubinstein PG, Chen YH.

Am J Hematol. 2008 Aug;83(8):684-5. doi: 10.1002/ajh.21201. No abstract available.

18.

Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.

Moser AM, Shalev H, Kapelushnik J.

Pediatr Hematol Oncol. 2002 Sep;19(6):407-11.

PMID:
12186363
19.

Treatment of acute immune thrombocytopenic purpura.

Tarantino MD, Goldsmith G.

Semin Hematol. 1998 Jan;35(1 Suppl 1):28-35. Review.

PMID:
9523747
20.

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB.

Blood. 1997 Apr 15;89(8):2689-700.

Supplemental Content

Support Center